NCT02578563View on ClinicalTrials.gov

Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus on SGLT 2 Inhibitor Therapy in Singapore

CompletedOBSERVATIONAL

Enrollment

201

Participants

Timeline

Start Date

February 12, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Diabetes Mellitus

Trial Locations (1)

Unknown

Research Site, Singapore

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY